From: Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact
Unadjusted OR | 95% CI | Adjusted OR | 95% CI | |
---|---|---|---|---|
Specimen type | ||||
LBC | 1 | - | 1 | - |
Self-taken swab | 0.59 | (0.45, 0.76) | 0.58 | (0..45, 0.75) |
Urine | 0.34 | (0.26, 0.44) | 0.33 | (0.25,0.44) |
SIMD | ||||
1: Most deprived | 1 | 1 | ||
2 | 0.78 | (0.62, 0.99) | 0.73 | (0.57, 0.93) |
3 | 0.96 | (0.75, 1.22) | 0.87 | (0.67, 1.12) |
4 | 0.78 | (0.60, 1.01) | 0.69 | (0.53, 0.91) |
5 Least deprived | 0.64 | (0.49, 0.82) | 0.62 | (0.48, 0.80) |
Urban rural classification | ||||
1: Large urban | 1 | - | 1 | - |
2: Other urban | 1.38 | (1.15, 1.67) | 1.41 | (1.16, 1.71) |
3-4: accessible/remote small towns | 1.19 | (0.90, 1.57) | 1.25 | (0.94, 1.66) |
5-6: accessible/remote rural | 1.60 | (1.24, 2.07) | 1.68 | (1.28, 2.20) |
Proportion of non-white residents in datazone | ||||
Q1 [0.0%-0.4%) | 1 | - | ||
Q2 [0.4%-1.0%) | 0.89 | (0.70, 1.14) | ||
Q3 [1.0%-2.0%) | 0.84 | (0.66, 1.08) | ||
Q4 [2.0%-5.3%) | 0.72 | (0.56, 0.92) | ||
Q5 [5.3%-65.6%) | 0.56 | (0.43, 0.73) |